Article3 Biotech2022

A strategy for in-house production of a positive selection cloning vector from the commercial pJET1.2/blunt cloning vector at minimal cost.

Omar Nawawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.